Terms: = Prostate cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A AND Diagnosis
48 results:
1. Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements.
Hemminki K; Försti A; Liska V; Kanerva A; Hemminki O; Hemminki A
Int J Cancer; 2023 May; 152(9):1837-1846. PubMed ID: 36571455
[TBL] [Abstract] [Full Text] [Related]
2. METTL3 preferentially enhances non-m
Wei X; Huo Y; Pi J; Gao Y; Rao S; He M; Wei Q; Song P; Chen Y; Lu D; Song W; Liang J; Xu L; Wang H; Hong G; Guo Y; Si Y; Xu J; Wang X; Ma Y; Yu S; Zou D; Jin J; Wang F; Yu J
Nat Cell Biol; 2022 Aug; 24(8):1278-1290. PubMed ID: 35927451
[TBL] [Abstract] [Full Text] [Related]
3. UVEAL METASTASIS BASED ON PATIENT AGE IN 1,111 PATIENTS: Comparison of Clinical Features and Outcomes Per Age Category.
Shields CL; Acaba-Berrocal LA; Selzer EB; Mayro EL; Newman JH; Malik K; Welch RJ; Shields JA
Retina; 2020 Feb; 40(2):204-213. PubMed ID: 31972789
[TBL] [Abstract] [Full Text] [Related]
4. [Role of eukaryotic translation initiation factor 4G in tumor].
Zhang S; Huang N; Pan X; Zang JL; Guan XX; Zhang JH; Liu LC; Lei XY
Sheng Li Xue Bao; 2016 Apr; 68(2):207-14. PubMed ID: 27108909
[TBL] [Abstract] [Full Text] [Related]
5. Male Pattern Baldness in Relation to prostate cancer-Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study.
Zhou CK; Levine PH; Cleary SD; Hoffman HJ; Graubard BI; Cook MB
Am J Epidemiol; 2016 Feb; 183(3):210-7. PubMed ID: 26764224
[TBL] [Abstract] [Full Text] [Related]
6. Reiki for depression and anxiety.
Joyce J; Herbison GP
Cochrane Database Syst Rev; 2015 Apr; (4):CD006833. PubMed ID: 25835541
[TBL] [Abstract] [Full Text] [Related]
7. Anthropometric Measures at Multiple Times Throughout Life and prostate cancer diagnosis, Metastasis, and Death.
Gerdtsson A; Poon JB; Thorek DL; Mucci LA; Evans MJ; Scardino P; Abrahamsson PA; Nilsson P; Manjer J; Bjartell A; Malm J; Vickers A; Freedland SJ; Lilja H; Ulmert D
Eur Urol; 2015 Dec; 68(6):1076-82. PubMed ID: 25794458
[TBL] [Abstract] [Full Text] [Related]
8. Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.
Lilja H; Cronin AM; Dahlin A; Manjer J; Nilsson PM; Eastham JA; Bjartell AS; Scardino PT; Ulmert D; Vickers AJ
Cancer; 2011 Mar; 117(6):1210-9. PubMed ID: 20960520
[TBL] [Abstract] [Full Text] [Related]
9. Patterns, art, and context: Donald Floyd Gleason and the development of the Gleason grading system.
Phillips JL; Sinha AA
Urology; 2009 Sep; 74(3):497-503. PubMed ID: 19376571
[TBL] [Abstract] [Full Text] [Related]
10. Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis.
Jani AB; Johnstone PA; Liauw SL; Master VA; Brawley OW
Am J Clin Oncol; 2008 Aug; 31(4):375-8. PubMed ID: 18845997
[TBL] [Abstract] [Full Text] [Related]
11. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
Levi F; Randimbison L; Te VC; Conconi MM; La Vecchia C
Int J Cancer; 2008 Dec; 123(12):2899-901. PubMed ID: 18770862
[TBL] [Abstract] [Full Text] [Related]
12. Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
Ulmert D; Serio AM; O'Brien MF; Becker C; Eastham JA; Scardino PT; Björk T; Berglund G; Vickers AJ; Lilja H
J Clin Oncol; 2008 Feb; 26(6):835-41. PubMed ID: 18281654
[TBL] [Abstract] [Full Text] [Related]
13. prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study.
Ulmert D; Cronin AM; Björk T; O'Brien MF; Scardino PT; Eastham JA; Becker C; Berglund G; Vickers AJ; Lilja H
BMC Med; 2008 Feb; 6():6. PubMed ID: 18279502
[TBL] [Abstract] [Full Text] [Related]
14. The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: towards a biologically-based screening strategy.
Vickers AJ; Ulmert D; Serio AM; Björk T; Scardino PT; Eastham JA; Berglund G; Lilja H
Int J Cancer; 2007 Nov; 121(10):2212-7. PubMed ID: 17657743
[TBL] [Abstract] [Full Text] [Related]
15. Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.
Lilja H; Ulmert D; Björk T; Becker C; Serio AM; Nilsson JA; Abrahamsson PA; Vickers AJ; Berglund G
J Clin Oncol; 2007 Feb; 25(4):431-6. PubMed ID: 17264339
[TBL] [Abstract] [Full Text] [Related]
16. cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program.
Hayat MJ; Howlader N; Reichman ME; Edwards BK
Oncologist; 2007 Jan; 12(1):20-37. PubMed ID: 17227898
[TBL] [Abstract] [Full Text] [Related]
17. Update on the Gleason grading system for prostate cancer: results of an international consensus conference of urologic pathologists.
Epstein JI; Allsbrook WC; Amin MB; Egevad LL
Adv Anat Pathol; 2006 Jan; 13(1):57-9. PubMed ID: 16462155
[TBL] [Abstract] [Full Text] [Related]
18. Survival patterns for the top four cancers in Canada: the effects of age, region and period.
Ugnat AM; Xie L; Semenciw R; Waters C; Mao Y
Eur J Cancer Prev; 2005 Apr; 14(2):91-100. PubMed ID: 15785312
[TBL] [Abstract] [Full Text] [Related]
19. [prostate cancer diagnosed before 55: a retrospective study from the Rare cancer Network].
Nguyen TD; Poortmans PM; van der Hulst M; Studer G; Pigois E; Collen TD; Belkacemi Y; Beckendorf V; Miralbell R; Scandolaro L; Soete G; Villa S; Gez E; Thomas O; Krengli M; Saliou M;
Bull Cancer; 2004 Dec; 91(12):959-64. PubMed ID: 15634636
[TBL] [Abstract] [Full Text] [Related]
20. Trends in survival for patients diagnosed with cancer in Vaud, Switzerland, between 1974 and 1993.
Levi F; Randimbison L; Te VC; Franceschi S; La Vecchia C
Ann Oncol; 2000 Aug; 11(8):957-63. PubMed ID: 11038031
[TBL] [Abstract] [Full Text] [Related]
[Next]
